Leaders in the handling, processing and storage of human tissue, particularly adipose (fat) & regenerative tissue, and cells.
Leaders in the handling, processing and storage of human tissue, particularly adipose (fat) & regenerative tissue, and cells.
The large majority of current tissue purification and cell separation technologies available on the market are focused on same-day processing at the expense of careful handling of tissue and cells to ensure high rates of viability and function. Their use of various processes, including enzymatic digestion mean that most of these may face serious issues with FDA and other regulatory bodies keen to regulate this new field. T&CT’s processes are focused on the cells, ensuring that they maintain their function and viability, and can survive prolonged periods of storage. As increased regulation of tissue and cell processing and storage is brought in, T&CT’s processes are already fully compliant with current FDA or European regulations and directives.
The large majority of current tissue purification and cell separation technologies available on the market are focused on same-day processing at the expense of careful handling of tissue and cells to ensure high rates of viability and function. Their use of various processes, including enzymatic digestion mean that most of these may face serious issues with FDA and other regulatory bodies keen to regulate this new field. T&CT’s processes are focused on the cells, ensuring that they maintain their function and viability, and can survive prolonged periods of storage. As increased regulation of tissue and cell processing and storage is brought in, T&CT’s processes are already fully compliant with current FDA or European regulations and directives.
Rebuilding following breast cancer treatment
Our unique Adiposet™ system dramatically improves the patient experience of breast reconstruction following breast cancer treatment, whilst improving clinical practice and reducing cost to NHS and private hospitals. Adiposet™ also has applications in many other reconstructive and cosmetic procedures.
Adiposet™ is in use in leading NHS breast cancer and reconstructive centres across the U.K. and Scotland.
Rebuilding following breast cancer treatment
Our unique Adiposet™ system dramatically improves the patient experience of breast reconstruction following breast cancer treatment, whilst improving clinical practice and reducing cost to NHS and private hospitals. Adiposet™ also has applications in many other reconstructive and cosmetic procedures.
Adiposet™ is in use in leading NHS breast cancer and reconstructive centres across the U.K. and Scotland.
Reconstruction & recovery following serious trauma
Our large volume fat grafting solutions, including Adiposet, and tissue handling & storage expertise provide critical assistance to difficult trauma reconstruction and can be crucial in wound healing.
Reconstruction & recovery following serious trauma
Our large volume fat grafting solutions, including Adiposet, and tissue handling & storage expertise provide critical assistance to difficult trauma reconstruction and can be crucial in wound healing.
Looking and feeling better with all natural cosmetic & facial filler products
The trend is now firmly toward ‘all natural’ fillers and cosmetic treatments, and our Regenerys™ range of products and services are superior to any current fat-based cosmetic filler, and not comparable to any artificial and man-made products such as botox and HA. Exclusively developed by us over a decade in the U.K. and delivered by experts in the field, the look and feel is all natural, and the product is concentrated with your the patient’s own regenerative factors.
Our proprietary Regenerys™ range launched in 2020 and is currently available in the U.K.
Looking and feeling better with all natural cosmetic & facial filler products
The trend is now firmly toward ‘all natural’ fillers and cosmetic treatments, and our Regenerys™ range of products and services are superior to any current fat-based cosmetic filler, and not comparable to any artificial and man-made products such as botox and HA. Exclusively developed by us over a decade in the U.K. and delivered by experts in the field, the look and feel is all natural, and the product is concentrated with your the patient’s own regenerative factors.
Our proprietary Regenerys™ range launched in 2020 and is currently available in the U.K.
Surviving serious & life-threatening burns
Our CryoSkin and MySkin range of cultured keratinocyte graft suspensions have been successfully used in all of the U.K.’s 5 main NHS burns centres for over 10 years and helped many people survive serious burns and wounds.
Although production is currently suspended in the U.K., the technical, regulatory and operational expertise developed during the research and delivery of these products and services for life-threatened patients underpins the current range and highlights the clinical credibility of the company. We aim to relaunch the product overseas as we expand in the coming years.
Surviving serious & life-threatening burns
Our CryoSkin and MySkin range of cultured keratinocyte graft suspensions have been successfully used in all of the U.K.’s 5 main NHS burns centres for over 10 years and helped many people survive serious burns and wounds.
Although production is currently suspended in the U.K., the technical, regulatory and operational expertise developed during the research and delivery of these products and services for life-threatened patients underpins the current range and highlights the clinical credibility of the company. We aim to relaunch the product overseas as we expand in the coming years.
Stem Cells and regenerative medicine
Adipose tissue (fat) is the most abundant source of Stem Cells in the adult body, as well as various regenerative factors and other cells. It is also relatively easy to access in reasonable quantities. A growing body of research is proving the value and benefit of the use of this tissue, particularly where the Stem Cells can be concentrated in the sample, across a wide range of treatments and procedures ranging from wound healing and skin regeneration, to serious reconstructive surgery and cultured tissue for various applications. T&CT has spent nearly 20 years advancing the technology of carefully handling, purifying, concentrating, culturing and storing adipose tissue, with a complete and enviable track record of clinical data over more than 10 years, and all within a comprehensive and fully compliant U.K. Human Tissue Authority quality assurance umbrella.
Stem Cells and regenerative medicine
Adipose tissue (fat) is the most abundant source of Stem Cells in the adult body, as well as various regenerative factors and other cells. It is also relatively easy to access in reasonable quantities. A growing body of research is proving the value and benefit of the use of this tissue, particularly where the Stem Cells can be concentrated in the sample, across a wide range of treatments and procedures ranging from wound healing and skin regeneration, to serious reconstructive surgery and cultured tissue for various applications. T&CT has spent nearly 20 years advancing the technology of carefully handling, purifying, concentrating, culturing and storing adipose tissue, with a complete and enviable track record of clinical data over more than 10 years, and all within a comprehensive and fully compliant U.K. Human Tissue Authority quality assurance umbrella.
Cryogenic tissue storage & cell viability
Our advanced technology and know-how have led to advances in the ability to store and unfreeze tissue samples, over a prolonged (>5 years) time, and have cell viability (active cells) of up to 90-95% post-thaw – an industry leading capability. All this means that cells and tissue that are then used in procedures are ‘live’ and capable of functioning, as opposed to largely dead or inactive cells. This high level of viability makes feasible many improvements, such as ‘staged’ procedures and improved scheduling.
Cryogenic tissue storage & cell viability
Our advanced technology and know-how have led to advances in the ability to store and unfreeze tissue samples, over a prolonged (>5 years) time, and have cell viability (active cells) of up to 90-95% post-thaw – an industry leading capability. All this means that cells and tissue that are then used in procedures are ‘live’ and capable of functioning, as opposed to largely dead or inactive cells. This high level of viability makes feasible many improvements, such as ‘staged’ procedures and improved scheduling.